Exact Sciences (EXAS) Common Equity (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Common Equity data on file, last reported at $2.4 billion in Q4 2025.

• Common Equity for Q4 2025 came in at $2.4 billion, changed 0.05% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.4 billion (changed 0.05% YoY), and the FY2025 annual result was $2.4 billion, changed 0.05% from the prior year.
• Common Equity fell to $2.4 billion in Q4 2025 per EXAS's latest filing, from $2.5 billion in the prior quarter.
• Over five years, Common Equity peaked at $3.6 billion in Q1 2021 and troughed at $2.4 billion in Q1 2025.
• A 5-year average of $3.0 billion and a median of $3.1 billion in 2023 frame the typical range for Common Equity.
• The sharpest annual moves came in 2021 and 2024: Common Equity soared 99.78% in 2021, then dropped 23.62% in 2024.
• A 5-year view of Common Equity shows it stood at $3.4 billion in 2021, then decreased by 10.17% to $3.0 billion in 2022, then climbed by 3.36% to $3.1 billion in 2023, then retreated by 23.62% to $2.4 billion in 2024, then dropped by 0.05% to $2.4 billion in 2025.
• Business Quant data shows EXAS's Common Equity at $2.4 billion in Q4 2025, $2.5 billion in Q3 2025, and $2.5 billion in Q2 2025.